Figure 3 | British Journal of Cancer

Figure 3

From: Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

Figure 3

(A) Ten-year distant disease-free survival (left) and breast cancer-specific survival (right) according to the 70-gene signature for the 40 patients with HER-2 positive and highly endocrine-responsive tumours according to the St. Gallen criteria (>50% ER positive and >50% PR positive). Out of the 11 low-risk patients, 7 were untreated, 4 received chemotherapy and one of these patients received trastuzumab. (B) Ten-year DDFS (left) and BCSS (right) for the 21 chemotherapy-naive patients.

Back to article page